# Seres Therapeutics, Inc.: Form 8-K, filed Oct 3, 2025

- Company: [Seres Therapeutics, Inc.](/companies/mcrb.md) (CIK 1609809)
- Form: 8-K
- Filed: 2025-10-03
- Accepted by EDGAR: Oct 3, 2025, 16:06 ET
- Period: 2025-09-23
- Accession: 0001193125-25-230118
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1609809/000119312525230118/d63317d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1609809/000119312525230118/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1609809/000119312525230118/d63317d8k.htm

Filed Oct 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-230118. Last ingested by Listed: Nov 4, 2026, 10:08 ET. No prices; not investment advice.